H71.30
Diffuse cholesteatosis, unspecified ear
Clinical Classification Guidelines
Medical Intelligence & Overview
Diffuse cholesteatosis of the ear is a condition characterized by the abnormal growth of keratinizing squamous epithelium within the middle ear and mastoid. This growth can lead to hearing loss, recurrent infections, and damage to surrounding structures if left untreated. The condition is often associated with chronic ear diseases and may be diagnosed through clinical examination and imaging. Recognizing the signs and understanding the causes, symptoms, and treatment options are essential for effective management.
Causes & Symptoms
Clinical Causes: ChronicOtitis media: Persistent inflammation of the middle ear can promote abnormal epithelial growth. Eustachian tube dysfunction: Impaired ventilation of the middle ear can lead to secretions and epithelial proliferation. Previous ear surgery or trauma: Surgical interventions or injuries can disrupt normal ear anatomy, increasing risk. Congenital abnormalities: Certain developmental conditions may predispose individuals to cholesteatoma formation. Repeated middle ear infections: Recurrent infections can cause tissue damage and facilitate abnormal growth.
Key Symptoms: Hearing loss: Gradual or sudden decrease in hearing ability. Ear fullness or pressure: Sensation of fullness in the affected ear. Persistent ear discharge: Often foul-smelling and may be chronic. Dizziness or balance problems: Due to involvement of nearby structures. Tinnitus: Ringing or buzzing sounds in the ear. Facial weakness: In advanced cases where adjacent nerves are affected.
Diagnostic & Treatment
Diagnosis Path: Diagnosing diffuse cholesteatosis involves a combination of clinical assessment and imaging. An otolaryngologist may perform a thorough ear examination using an otoscope to observe abnormal tissue growth, perforations, or debris. Hearing tests such as audiometry can evaluate the extent of hearing impairment. Imaging studies like CT scans provide detailed views of the middle ear and mastoid, helping to assess the extent of cholesteatoma and its impact on surrounding structures. Sometimes, surgery or biopsy confirms the diagnosis.
Treatment Protocols: Treatment typically involves surgical intervention to remove the cholesteatoma and prevent further complications. Procedures such as a mastoidectomy or tympanoplasty aim to excise abnormal tissue, restore ear function, and address any damage. Postoperative care may include antibiotics to treat or prevent infections and regular follow-up to monitor for potential recurrence. In some cases, hearing rehabilitation or assistive devices may be recommended to improve hearing capacity. Managing underlying causes, such as Eustachian tube dysfunction, is also important to prevent recurrence.
Clinical Advice & FAQs
Billing Guidance
Is H71.30 a billable ICD-10 code?
Yes, H71.30 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H71.30?
Clinical documentation must specify the nature of Diffuse cholesteatosis, unspecified ear and any associated comorbidities for accurate reporting.
Cite this Clinical Reference